These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37021365)

  • 41. Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study.
    Cheikh Hassan HI; Murali K; Lonergan M; Boudville N; Johnson D; Borlace M; Chen JHC
    Kidney Int Rep; 2022 Nov; 7(11):2388-2396. PubMed ID: 36531876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study.
    Ma X; Shi Y; Tao M; Jiang X; Wang Y; Zang X; Fang L; Jiang W; Du L; Jin D; Zhuang S; Liu N
    BMJ Open; 2020 Feb; 10(2):e029949. PubMed ID: 32060152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study.
    Zhang W; Tan Y; Ai J; Luo F; Su X; Wu Q; Su L; Pan J; Zheng Q; Li B; Chen J; Luo Q; Chen J; Dou X
    Ann Transl Med; 2022 Nov; 10(22):1212. PubMed ID: 36544662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lower education level is a major risk factor for peritonitis incidence in chronic peritoneal dialysis patients: a retrospective cohort study with 12-year follow-up.
    Chern YB; Ho PS; Kuo LC; Chen JB
    Perit Dial Int; 2013; 33(5):552-8. PubMed ID: 23547277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.
    Borg D; Shetty A; Williams D; Faber MD
    Adv Perit Dial; 2003; 19():202-5. PubMed ID: 14763063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.
    van Diepen AT; van Esch S; Struijk DG; Krediet RT
    Perit Dial Int; 2016 9-10; 36(5):533-9. PubMed ID: 27044793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peritonitis: Episode Sequence, Microbiological Variation, Risk Factors and Clinical Outcomes in a North China Peritoneal Dialysis Center.
    Hu S; Ming P; Qureshi AR; Lindholm B; Bo Y; Yang H
    Kidney Blood Press Res; 2018; 43(5):1573-1584. PubMed ID: 30347399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes.
    Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Bannister KM; Clayton PA; Johnson DW
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1556-63. PubMed ID: 23949232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term impact of early non-infectious complications at the initiation of peritoneal dialysis.
    Chan R; Walker RJ; Samaranayaka A; Schollum J
    Perit Dial Int; 2023 Jan; 43(1):53-63. PubMed ID: 36325812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients.
    van Diepen AT; van Esch S; Struijk DG; Krediet RT
    Perit Dial Int; 2015; 35(3):324-32. PubMed ID: 24711641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane transport status does not predict peritonitis risk in patients on peritoneal dialysis.
    So S; Aw L; Sud K; Lee VW
    Nephrology (Carlton); 2018 Jul; 23(7):633-639. PubMed ID: 28437596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients.
    Martin LC; Caramori JC; Fernandes N; Divino-Filho JC; Pecoits-Filho R; Barretti P;
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):1944-51. PubMed ID: 21737854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: A retrospective study.
    Tian Y; Xie X; Xiang S; Yang X; Zhang X; Shou Z; Chen J
    Medicine (Baltimore); 2016 Dec; 95(49):e5569. PubMed ID: 27930566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and Risk Factors Associated with Technique Failure in the First Year of Peritoneal Dialysis: A Single Center Retrospective Cohort Study in Southern China.
    Dong X; Wu H; Ye H; Yi C; Diao X; Liu R; Mao H; Huang F; Yu X; Yang X
    BMC Nephrol; 2022 Jun; 23(1):207. PubMed ID: 35690721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of Potassium Supplementation in Hypokalemic Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial.
    Pichitporn W; Kanjanabuch T; Phannajit J; Puapatanakul P; Chuengsaman P; Parapiboon W; Treamtrakanpon W; Boonyakrai C; Matayart S; Katavetin P; Perl J; Praditpornilpa K; Eiam-Ong S; Tungsanga K; Johnson DW
    Am J Kidney Dis; 2022 Nov; 80(5):580-588.e1. PubMed ID: 35597332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients.
    Maeda S; Yamaguchi M; Maeda K; Kobayashi N; Izumi N; Nagai M; Obayashi T; Ohashi W; Katsuno T; Nobata H; Ito Y
    PLoS One; 2019; 14(11):e0224859. PubMed ID: 31697753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk Factors for Early-Onset Peritonitis in Southern Chinese Peritoneal Dialysis Patients.
    Wu H; Huang R; Yi C; Wu J; Guo Q; Zhou Q; Yu X; Yang X
    Perit Dial Int; 2016 11-12; 36(6):640-646. PubMed ID: 27147289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis.
    Kerschbaum J; Vychytil A; Lhotta K; Prischl FC; Wiesholzer M; Machhold-Fabrizii V; Kopriva-Altfahrt G; Schwarz C; Balcke P; Oberbauer R; Kramar R; König P; Rudnicki M
    PLoS One; 2013; 8(7):e67836. PubMed ID: 23844107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis.
    Chang D; Xu X; Yang Z; Ma T; Nie J; Dong J
    Perit Dial Int; 2022 Nov; 42(6):622-630. PubMed ID: 34724845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between initial peritoneal dialysis modality and risk of peritonitis.
    Kokubu M; Matsui M; Uemura T; Morimoto K; Eriguchi M; Samejima K; Akai Y; Tsuruya K
    Sci Rep; 2020 Oct; 10(1):18763. PubMed ID: 33127929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.